[{"address1": "455 North Bernardo Avenue", "city": "Mountain View", "state": "CA", "zip": "94043", "country": "United States", "phone": "(650) 237-2700", "fax": "(650) 237-2701", "website": "https://www.neuropace.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.", "fullTimeEmployees": 195, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joel D. Becker", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 920381, "exercisedValue": 0, "unexercisedValue": 916191}, {"maxAge": 1, "name": "Ms. Rebecca L. Kuhn", "age": 63, "title": "CFO and VP of Finance & Administration", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 591917, "exercisedValue": 0, "unexercisedValue": 2503945}, {"maxAge": 1, "name": "Dr. Martha J. Morrell M.D.", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 668162, "exercisedValue": 0, "unexercisedValue": 1882065}, {"maxAge": 1, "name": "Mr. Dylan  St. John", "title": "Chief of Operations & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah  Akin", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Katie  Keller", "title": "Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chris  Reese", "title": "Senior Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Treadwell", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.28, "open": 13.35, "dayLow": 12.87, "dayHigh": 13.84, "regularMarketPreviousClose": 13.28, "regularMarketOpen": 13.35, "regularMarketDayLow": 12.87, "regularMarketDayHigh": 13.84, "payoutRatio": 0.0, "beta": 2.042, "forwardPE": -12.523809, "volume": 212246, "regularMarketVolume": 212246, "averageVolume": 284434, "averageVolume10days": 521390, "averageDailyVolume10Day": 521390, "bid": 13.06, "ask": 13.22, "bidSize": 1, "askSize": 1, "marketCap": 431300256, "fiftyTwoWeekLow": 5.45, "fiftyTwoWeekHigh": 18.975, "priceToSalesTrailing12Months": 5.1158905, "fiftyDayAverage": 12.8837, "twoHundredDayAverage": 10.6303, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 438190336, "profitMargins": -0.29423, "floatShares": 21326572, "sharesOutstanding": 32798500, "sharesShort": 400485, "sharesShortPriorMonth": 347479, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.012200001, "heldPercentInsiders": 0.02579, "heldPercentInstitutions": 0.8559, "shortRatio": 1.95, "shortPercentOfFloat": 0.0207, "impliedSharesOutstanding": 32798500, "bookValue": 0.741, "priceToBook": 17.746288, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -24805000, "trailingEps": -0.82, "forwardEps": -1.05, "enterpriseToRevenue": 5.198, "enterpriseToEbitda": -22.988, "52WeekChange": 1.0451012, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 13.15, "targetHighPrice": 20.0, "targetLowPrice": 15.0, "targetMeanPrice": 17.125, "targetMedianPrice": 17.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 66262000, "totalCashPerShare": 2.02, "ebitda": -19062000, "totalDebt": 73152000, "quickRatio": 5.555, "currentRatio": 6.628, "totalRevenue": 84306000, "debtToEquity": 301.422, "revenuePerShare": 2.817, "returnOnAssets": -0.11524, "returnOnEquity": -1.2849001, "grossProfits": 63084000, "freeCashflow": -9892750, "operatingCashflow": -17903000, "revenueGrowth": 0.243, "grossMargins": 0.74827003, "ebitdaMargins": -0.22610001, "operatingMargins": -0.22850999, "financialCurrency": "USD", "symbol": "NPCE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Neuropace, Inc.", "marketState": "CLOSED", "ipoExpectedDate": "2021-04-22", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.978917, "regularMarketPrice": 13.15, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1619098200000, "postMarketChangePercent": -3.22433, "postMarketPrice": 12.726, "postMarketChange": -0.424, "regularMarketChange": -0.13, "regularMarketDayRange": "12.87 - 13.84", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 284434, "fiftyTwoWeekLowChange": 7.7, "fiftyTwoWeekLowChangePercent": 1.4128441, "fiftyTwoWeekRange": "5.45 - 18.975", "fiftyTwoWeekHighChange": -5.825001, "fiftyTwoWeekHighChangePercent": -0.3069829, "fiftyTwoWeekChangePercent": 104.51012, "earningsTimestamp": 1747166701, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "earningsCallTimestampStart": 1747168200, "earningsCallTimestampEnd": 1747168200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.82, "epsForward": -1.05, "epsCurrentYear": -0.80901, "priceEpsCurrentYear": -16.254433, "fiftyDayAverageChange": 0.26629925, "fiftyDayAverageChangePercent": 0.02066947, "twoHundredDayAverageChange": 2.5197, "twoHundredDayAverageChangePercent": 0.23703001, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "longName": "NeuroPace, Inc.", "corporateActions": [], "postMarketTime": 1749253900, "regularMarketTime": 1749240000, "exchange": "NGM", "messageBoardId": "finmb_125322", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "NeuroPace", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]